Updated March 5 at 6:05pm
Biotechnology
43 results total, viewing 31 - 40
MedMates grew up out of a simple premise: Put enough health-tech industry members in a room together, and innovation will take care of itself. more
Venture capitalists invested $124.1 million in Rhode Island companies in 2014, $42 million more than in 2013, and the largest amount to date, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association. more
Global biotech firm Covidien PLC reported Friday that its net income rose five-tenths of a percent in its fiscal second quarter, totaling $441 million, or 97 cents per diluted share, compared with $439 million, or 92 cents per diluted share, during the same period a year earlier. more
Dr. Anne S. De Groot, EpiVax CEO and University of Rhode Island professor, has been named one of the most influential people in the vaccine industry by the national vaccine industry organization VaccineNation. more
Steve Lombardi has been named CEO and president of Nabsys Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis. more
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the four winners of its second annual Rhode Island Bioscience Awards. more
Amgen Inc., the world’s biggest biotechnology company by sales, reported second-quarter earnings that beat analysts’ estimates and raised its profit estimate for the year. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
The Bill and Melinda Gates Foundation has awarded a $100,000 grant to the GAIA Vaccine Foundation to raise awareness about the prevention of cervical cancer in West Africa. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »